India Pharma Forum: What The FDA, Indian Regulator Flagged Up
Regulators Discuss Cross Contamination Risks, Quality Culture, ‘Filtered’ Harmonization
The two-day India Pharmaceutical Forum in Mumbai highlighted key aspects of quality management and its challenges, trends on inspection outcomes in India and emerging concerns of 'dangerous cross contamination.'
